Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
4 vehicles on file, newest listing first
8 of 9 appear on more than one
3 people on two or more of them
Becky Fallon serves as an Independent Director on the Board of Directors of Futurewave Acquisition Corporation (NASDAQ: FWACU), a Cayman Islands exempted blank check company that priced its $75 million IPO on June 25, 2026, with units trading on the Nasdaq under the symbol FWACU. Headquartered at 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036, Futurewave was founded on February 16, 2026, and is led by Chairman, Chief Executive, and Financial Officer Daniel M. McCabe. Fallon sits on the board alongside fellow independent directors Sean Michael Deegan and Robert Labbe. She filed her initial Form 3 beneficial ownership statement on July 3, 2026, and has entered into an indemnity agreement with the company in her capacity as director. The SPAC is pursuing a generalist search for a business combination target, leveraging the contacts and experience of its management team. Fallon is approximately 65 years old as of 2026.
Beyond her SPAC governance role, Fallon is a distinguished PhD neuroscientist whose career bridges academic research and the commercial scientific enterprise. She currently serves as a Territory Manager in the Midwest at Inscopix, Inc., a Bruker company, where she advances neuroscience research through innovative technologies. Her prior roles include serving as a Scientific Consultant at Noldus Information Technology, where she advised on projects aimed at enhancing behavioral research methodologies and data analysis, and as an Intramural Research Training Award Graduate Fellow at the National Institutes of Health (NIH), where she collaborated with leading scientists on groundbreaking research. Her early career included work as a Research Specialist at the Medical University of South Carolina (MUSC), where she developed extensive laboratory experience and a strong foundation in the scientific method. She has also been associated with the National Institute on Drug Abuse (NIDA).
Fallon earned her Doctor of Philosophy (PhD) from The Johns Hopkins University (2011–2017) through the Cellular, Molecular, Developmental Biology, and Biophysics Program, focusing on the biological processes underlying cognitive functions and behaviors. Prior to her doctoral studies, she received her Bachelor's Degree in Brain and Cognitive Sciences from the University of Rochester. She has authored and contributed to research papers in reputable journals, establishing herself as a thought leader in neuroscience and behavioral research. Her unique combination of deep scientific expertise, consulting experience, and scientific sales acumen positions her to bridge the gap between complex research and practical market applications. Based in the Greater Chicago area, Fallon brings a distinctive interdisciplinary perspective to the Futurewave board, complementing the financial and operational backgrounds of her fellow directors as the SPAC seeks to identify and complete a qualifying business combination.
This record is keyed to SEC CIK 0002130692 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 4 institutional-holder rows on these vehicles, under 3 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.